This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morgan, T. Articles by Ward, K. Search for Related Content PubMed PubMed Citation Articles by Morgan, T. Articles by Ward, K.

(Hypertension. 1998;32:683-687.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Human Spiral Artery Renin-Angiotensin System

Terry Morgan; Catherine Craven; ; Kenneth Ward

From the Departments of Human Genetics (T.M., K.W.) and Obstetrics and Gynecology (C.C., K.W.), University of Utah Health Sciences Center, Salt Lake City.

Abstract—Pregnancy induces uterine spiral arteries to remodel into dilated uteroplacental vessels by an unknown mechanism called "physiological change." In women who develop preeclampsia, however, many spiral arteries remain unchanged or develop medial hyperplasia and atherosis. We recently demonstrated that angiotensinogen is expressed by remodeling spiral arteries in first-trimester decidua. We hypothesize that a local spiral artery renin-angiotensin system mediates pregnancy-induced remodeling of these vessels. In this study we tested for expression of renin, angiotensin-converting enzyme, and angiotensin II type 1 receptor genes in the first-trimester uterus using reverse-transcription polymerase chain reaction. Expression was localized by in situ hybridization and immunohistochemistry. Renin, angiotensin-converting enzyme, and the angiotensin II type 1 receptor are all expressed in and around remodeling spiral arteries. These observations suggest that a local spiral artery renin-angiotensin system may play a role in pregnancy-induced remodeling of these vessels. Elevated angiotensinogen expression in women homozygous for the A(-6) variant in the angiotensinogen promoter may promote abnormal remodeling, whereas relatively lower levels in women homozygous for G(-6) may permit enough normal remodeling to protect these women from preeclampsia.

Key Words: renin-angiotensin system • arteries • preeclampsia • human

This article has been cited by other articles:

				L. Anton, D. C. Merrill, L. A.A. Neves, K. Stovall, P. E. Gallagher, D. I. Diz, C. Moorefield, C. Gruver, C. M. Ferrario, and K. B. Brosnihan Activation of Local Chorionic Villi Angiotensin II Levels But Not Angiotensin (1-7) in Preeclampsia Hypertension, April 1, 2008; 51(4): 1066 - 1072. [Abstract] [Full Text] [PDF]

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				H. A. Kadi, H. Nasrat, and F. B. Pipkin A prospective, longitudinal study of the renin-angiotensin system, prostacyclin and thromboxane in the first trimester of normal human pregnancy: association with birthweight Hum. Reprod., November 1, 2005; 20(11): 3157 - 3162. [Abstract] [Full Text] [PDF]

				E. Takimoto-Ohnishi, T. Saito, J. Ishida, J. Ohnishi, F. Sugiyama, K.-I. Yagami, and A. Fukamizu Differential Roles of Renin and Angiotensinogen in the Feto-Maternal Interface in the Development of Complications of Pregnancy Mol. Endocrinol., May 1, 2005; 19(5): 1361 - 1372. [Abstract] [Full Text] [PDF]

				D. M. Shah Role of the renin-angiotensin system in the pathogenesis of preeclampsia Am J Physiol Renal Physiol, April 1, 2005; 288(4): F614 - F625. [Abstract] [Full Text] [PDF]

				S. Levesque, J.-M. Moutquin, C. Lindsay, M.-C. Roy, and F. Rousseau Implication of an AGT Haplotype in a Multigene Association Study With Pregnancy Hypertension Hypertension, January 1, 2004; 43(1): 71 - 78. [Abstract] [Full Text] [PDF]

				G. Mello, E. Parretti, F. Gensini, E. Sticchi, F. Mecacci, G. Scarselli, M. Genuardi, R. Abbate, and C. Fatini Maternal-Fetal Flow, Negative Events, and Preeclampsia: Role of ACE I/D Polymorphism Hypertension, April 1, 2003; 41(4): 932 - 937. [Abstract] [Full Text] [PDF]

				Y. Yamamoto, T. Maruyama, N. Sakai, R. Sakurai, A. Shimizu, T. Hamatani, H. Masuda, H. Uchida, H. Sabe, and Y. Yoshimura Expression and subcellular distribution of the active form of c-Src tyrosine kinase in differentiating human endometrial stromal cells Mol. Hum. Reprod., December 1, 2002; 8(12): 1117 - 1124. [Abstract] [Full Text] [PDF]

				M. Ito, A. Itakura, Y. Ohno, M. Nomura, T. Senga, T. Nagasaka, and S. Mizutani Possible Activation of the Renin-Angiotensin System in the Feto-Placental Unit in Preeclampsia J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1871 - 1878. [Abstract] [Full Text] [PDF]

				K. F. Hilgers, C. Delles, R. Veelken, and R. E. Schmieder Angiotensinogen Gene Core Promoter Variants and Non-Modulating Hypertension Hypertension, December 1, 2001; 38(6): 1250 - 1254. [Abstract] [Full Text] [PDF]

				F. Clayton, D. P. Kotler, S. K. Kuwada, T. Morgan, C. Stepan, J. Kuang, J. Le, and J. Fantini Gp120-Induced Bob/GPR15 Activation : A Possible Cause of Human Immunodeficiency Virus Enteropathy Am. J. Pathol., November 1, 2001; 159(5): 1933 - 1939. [Abstract] [Full Text] [PDF]

				R. N. Re On Not Being the Last to Give Up the Old or the First to Adopt the New Hypertension, October 1, 2001; 38(4): 759 - 760. [Full Text] [PDF]

				M. Christiansen, I. Jaliashvili, M. T. Overgaard, C. Ensinger, P. Obrist, and C. Oxvig Quantification and Characterization of Pregnancy-associated Complexes of Angiotensinogen and the Proform of Eosinophil Major Basic Protein in Serum and Amniotic Fluid Clin. Chem., August 1, 2000; 46(8): 1099 - 1105. [Abstract] [Full Text] [PDF]

				C. Li, R. Ansari, Z. Yu, and D. Shah Definitive Molecular Evidence of Renin-Angiotensin System in Human Uterine Decidual Cells Hypertension, August 1, 2000; 36(2): 159 - 164. [Abstract] [Full Text] [PDF]